National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
HBV, HCV pose a major health problem throughout the world. Due to invasive procedure patients undergoing hemodialysis are at high risk of acquiring infections. Infections acquired in dialysis unit can prolong hospitalization thus increasing the current study intended at detecting the prevalence of HBV and HCV infection among hemodialysis patients exercising the Rapid Immunochromatographic Test (ICT) and enzyme-linked immunosorbent assay (ELISA). Conventional ELISA is regarded as the most used screening test but due to limitations like high cost, unavailability, time consuming nature and requirement of skilled personnel for interpretation of result, rapid tests are gaining more importance and warrants comparison of performance. All test samples ranged in age group (15-76) years. Test results revealed (39.3%) positive for HBV and (59.0%) positive for HCV in rapid ICT. ELISA further verified tested samples for confirmed results. This study showed that there is high prevalence of HBV and HCV infection among patients undergoing hemodialysis. Hence, stern adherence to infection prevention and control measures, isolation of seropositive patients, ample screening of HBV and HCV for donated blood and donors is indispensable to minimize the risk of HBV and HCV infections.
Arankalle V A, Chadha M S, Jha J, Amrapurkar D N, Banerjee K. Prevalence of anti-HCV antibodies in western India. Indian J Med Res. 1995;101:91e93.
Chandra M, Khaja M N, Hussain M M, et al., Prevalence of hepatitis B and C viral infections in Indian patients with chronic renal failure. Intervirology 2004;47:374-76. https://doi.org/10.1159/000080883
Doerrbecker J, Behrendt P, Mateu Gelabert P, Ciesek S, Riebesehl N, Wilhelm C, Steinmann Pietschmann T, Steinmann E (2013) Transmission of Hepatitis C Virus among People Who Inject Drugs: Viral Stability and Association With Drug Preparation Equipment HCV and Drug Preparation Equipment. JID: 207 (15): 281-287. https://doi.org/10.1093/infdis/jis677
Edey M, Barraclough K, Johnson D W. Hepatitis B and dialysis. Nephrology. 2010; 15(2):137–45. https://doi.org/10.1111/j.1440-1797.2009.01268.x
Fabrizi F, Messa P, Martin P. Hepatitis B virus infection and the dialysis patient. Semin Dial. 2008;21(5):440-446. https://doi.org/10.1111/j.1525-139X.2008.00437.x
Gosavi M S, Shah S K, Shah S R, Pal R B, Saldanha J A, Banker D D. Prevalence of hepatitis C virus (HCV) infection in Mumbai. Indian J Med Sci. 1997;51:378e385.
Iwasa Y, Otsubo S, Sugi O, Sato K, Asamiya Y, Eguchi A, et al., Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clinical and experimental nephrology. 2008; 12 (1):53–7. https://doi.org/10.1007/s10157-007-0005-6
Kuhns M C, Busch M P, et al., New strategies for blood donor screening for hepatitis B virus: Nucleic acid testing versus immunoassay methods. Mol Diagn Ther 2006;10:77-91. https://doi.org/10.1007/BF03256447
Kumar V, Das S, Jameel S. The biology and pathogenesis of hepatitis viruses. Current science. 2010:312–25.
Muller G Y, Zabaleta M E, Arminio A, Colmenares C J, Capriles F I, Bianco N E, et al., Risk factors for dialy- sis-associated hepatitis C in Venezuela. Kidney international. 1992; 41(4):1055–8. https://doi.org/10.1038/ki.1992.160
Oesterreicher C, Muller C. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int. 1995;48:1967-1971. https://doi.org/10.1038/ki.1995.498
Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney interna- tional. 1997; 51(4):981–99. https://doi.org/10.1038/ki.1997.139
Reddy G A, Dakshinamurthy K V, Neelaprasad P, Ganghadhar T, Lakshmi V. Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian Journal of Medical Microbiology 2005, 10/23, Issue I: 41-43. https://doi.org/10.4103/0255-0857.13872
Sit D, Kadiroglu A K, Kayabasi H, Yilmaz M E, Goral V. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey. Intervirol- ogy. 2007; 50(2):133–7. https://doi.org/10.1159/000098239
Wright T L, Pereira B J G. Hepatitis C virus: a threat without a cure to the patient with ESRD. Semin Dial. 1997;10(5):241-247.
Citations |
 |
 |
 |
 |
